Source comparison
GHRP-6 vs Ipamorelin: Comparative Safety Research
A recurring theme in GHRP-6 safety literature is its comparison to Ipamorelin, a more selective GH secretagogue that binds GHS-R1a with higher selectivity and does not produce the same degree of cortisol, prolactin, or appetite stimulation. Research characteri
This comparison does not assign a generated winner or score.
- A recurring theme in GHRP-6 safety literature is its comparison to Ipamorelin, a more selective GH secretagogue that binds GHS-R1a with higher selectivity and does not produce the same degree of cortisol, prolactin, or appetite stimulation. Research characterizing GHRP-6 safety relative to Ipamorelin consistently identifies GHRP-6 as the less selective compound, with a broader side effect profile arising from its more comprehensive ghrelin receptor activation.